| Literature DB >> 35407332 |
Surabhi Jaiswal1,2, Amit Manhas1, Alok Kumar Pandey3, Smriti Priya3, Sandeep K Sharma1,2.
Abstract
Engineered nanoparticles (ENPs) are artificially synthesized particles with unique physicochemical properties. ENPs are being extensively used in several consumer items, elevating the probability of ENP exposure to biological systems. ENPs interact with various biomolecules like lipids, proteins, nucleic acids, where proteins are most susceptible. The ENP-protein interactions are mostly studied for corona formation and its effect on the bio-reactivity of ENPs, however, an in-depth understanding of subsequent interactive effects on proteins, such as alterations in their structure, conformation, free energy, and folding is still required. The present review focuses on ENP-protein interactions and the subsequent effects on protein structure and function followed by the therapeutic potential of ENPs for protein misfolding diseases.Entities:
Keywords: aggregation; engineered nanoparticles; misfolding; molecular chaperones; nanochaperones; protein; protein corona; protein folding
Year: 2022 PMID: 35407332 PMCID: PMC9002493 DOI: 10.3390/nano12071214
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Techniques used in the synthesis of nanoparticle.
| Nanoparticle Synthesis Approach | Techniques | Description | Reference |
|---|---|---|---|
| Top-down approach | Synthesis is initiated by systematic leaching of bulk counterpart leading to the generation of nano-scaled particles. | ||
| Lithography | Categorized as masked and maskless lithography. In masked lithography transfer of nano-patterns over a large surface area is done using a specific mask e.g., photolithography and soft lithography. In maskless lithography, arbitrary nanopattern is written without using any mask e.g., electron beam lithography and focussed ion beam lithography. | [ | |
| Mechanical milling | Formation of nano-scaled material by elastic, plastic and shear deformation followed by fracture, amorphization and chemical reactions. It helps in nanocomposite production. | [ | |
| Electrospinning | Used for nanofibres production from various materials, typically polymers. | [ | |
| Sputtering | Nanomaterials are produced by the bombardment of high-energy particles such as gas or plasma on the solid surface. Used for the production of thin films of nanomaterials. | [ | |
| Arc discharge method | Used for the production of carbon-based materials such as fullerenes, carbon nanotubes etc. | [ | |
| Laser ablation | Nanomaterials synthesized using a powerful beam of laser that hits the target. | [ | |
| Bottom-up approach | Synthesis is by coalescence or assembling of atoms and molecules to produce various nanoparticles. | ||
| Sol-gel method | Metal oxide nanoparticles are synthesized by the transformation of liquid precursor to a sol followed by its conversion into a gel. | [ | |
| Chemical vapour deposition | Nanomaterials are synthesized by thin film formation over the surface of the substrate due to the chemical reaction of vapor-phase precursors. | [ | |
| Hydrothermal and solvothermal methods | Nanomaterials are synthesized in either aqueous medium (hydrothermal method) or non-aqueous medium (solvothermal method) by heterogeneous reaction under high pressure and temperature near the critical point in an enclosed vessel. | [ | |
| Template methods | These are used to synthesize nanoporous materials either by using a soft template such as block polymers and surfactants or by using a hard template such as carbon nanotubes, carbon black, wood shells, silica and colloidal crystals. | [ | |
| Reverse micelle methods | Nanoparticles are synthesized by the formation of reverse micelle which is created in the case of water-in-oil emulsion where hydrophilic heads point towards the core. This core act as a nanoreactor for nanoparticle synthesis. | [ |
Types of ENPs, their characteristics, and applications.
| ENPs Types | Size (nm) | Characteristics | Applications | References |
|---|---|---|---|---|
|
Organic | ||||
| Dendrimers | <10 nm | Radially symmetric molecules with highly branched structures made of one or more cores. These are homogeneous and monodispersed. | Controlled and targeted bioactive delivery to macrophages, liver targeting, transdermal drug delivery, gene delivery | [ |
| Liposome | 50–100 nm | Vesicles of phospholipid with superior entrapment ability. These are biocompatible and versatile. | Passive and active gene delivery, can be used for peptides, proteins, and cell interactions studies, anti-cancer therapy | [ |
|
Polymeric | 10–1000 nm | Biodegradable and biocompatible. | Controlled and sustained drug delivery carriers, protein carriers, intra-arterial localization of therapeutic agents | [ |
| Micelles | 10–100 nm | Formed of amphiphilic | Targeted delivery of siRNA and anticancer drug, diagnosis | [ |
|
Inorganic | ||||
| Metallic | <100 nm | Metal colloids with a high surface-to-volume ratio. These are stable and have better mechanical strength, optical and magnetic properties. | Delivery of genes and drugs, ultrasensitive diagnostic assays, radiotherapy, and thermal ablation | [ |
| Metal oxide | <100 nm | Oxides of metals with antioxidant activities, chemical stability, catalytic and optical properties, and biocompatibility. | Medical implants, drug delivery, biological antioxidant, bioimaging, biosensors | [ |
| Ceramic | <50 nm | Non-metallic solids of non-metallic and metallic compounds with the property of heat resistance. | Bone repair, drug delivery vehicles, photocatalysis, imaging, photodegradation of dyes | [ |
|
Nanocrystal | 2–9.5 nm | Semiconductive material consists of a semiconductor core, a shell, and a cap. These have high photostability, broad UV excitation, narrow emission, bright fluorescence, and resistance to photobleaching. | Long-term multi-colour imaging of hepatocytes, DNA hybridization, immunoassays, receptor-mediated endocytosis, disease marker labeling | [ |
| Fullerenes | 1–2 nm | High strength, electrical conductivity, electron affinity, and versatile structure. | Gene and drug delivery, antiviral activity | [ |
|
Carbon | 0.5–3 nm in | These are single or multi-walled nanotubes with unique strength and electrical properties. Found in crystalline form. | Can penetrate inside cell and nucleus, gene and peptide carrier, used in imaging, drug delivery, tissue engineering | [ |
|
Hybrid | ||||
| Hydrogels | 0.1 to 100 μm | These are also known as polymeric nanogels and macromolecules micelles. These are polymeric networks having a three-dimensional structure with high water or biological fluid absorbing capacity owing to the hydrophilic groups present in the polymer chains. | These are used in the delivery of drugs of small molecular weight, peptides, proteins, nucleic acids, oligosaccharides and vaccines. | [ |
Figure 1Interaction mechanism of biopolymer-coated AuNPs mediated inhibition of insulin amyloid fibrillation. The formation of amyloid fibrils is a multi-step process. Interaction of biopolymer-coated AuNPs with insulin monomers during the nucleation step of fibrillation inhibits the insulin amyloid fibril formation. These ENPs strongly interact with insulin monomers via their –OH and –NH2 groups thereby, inhibiting oligomer formation and protofibril elongation resulting in the formation of thin and short fibrils.
Figure 2Factors governing ENP-protein interactions and the subsequent effect of these interactions on the protein conformation and function. ENP-protein interaction results in attraction between ENPs and proteins having opposite charges and repulsion between like charges. As proteins are among the first molecules with which ENPs interact after their entry inside the biological systems, therefore, this interaction facilitates passage through the semi-permeable plasma membrane of the cells. Further, these ENPs may modulate protein folding processes such as unfolding, refolding, misfolding, aggregation and fibrillation.
Studies showing involvement of ENPs in protein modulation.
| ENPs | Protein/Model Used | Disease | Outcome | Reference |
|---|---|---|---|---|
| Zinc oxide nanoparticles (ZnO NPs), short ZnO nanorods (s-ZnO NRs), and long ZnO nanorods (l-ZnO NRs) | Human and zebrafish larvae neuroblastoma cells SH-SY5Y | Parkinson’s | PD like symptoms developed | [ |
| CuO nanoparticles (CuONP), Fe2O3 nanoparticles (Fe2O3NP), ZnONP | Rat cell lines (PC12) and human SH-SY5Y and H4 cells | Alzheimer’s | Concentration-based neurotoxicity of CuONP but not Fe2O3NP and ZnONP. CuONP as an environmental risk factor for AD | [ |
| Poly(trehalose) nanoparticles | HD150Q cells, HD transgenic mice [B6CBA-Tg (HDexon1) 62Gpb/3Jstrain] | Huntington’s disease (HD) | Inhibition of amyloid aggregation and prevention of polyglutamine aggregation. | [ |
| Carbon nanoparticles (graphene and carbon nanotubes) | Mouse prion protein (moPrP117−231) | Prions disease | Carbon nanoparticles inhibited Prion fibrillation in In vitro studies SWCNT and graphene reduced interaction of peptide and caused the formation of β-structure | [ |
| Nanoliposomes (NL) | Purified AL light chain proteins, ex-vivo human arteriole model, Human aortic artery endothelial cells (HAEC) | Light chain amyloidosis (AL) | Increased folded protein amount, reduced cell internalization. | [ |
| Dendrimer–tesaglitazar | BV2 murine microglial cell line | AD and PD | Microglial phynotype shift, increased β-amyloid phagocytosis | [ |
| Graphene QDs | 10 DIV mouse cortical neurons, C57BL/6 mice | PD | Inhibition of α-syn fibril formation, trigger fibril disaggregation, protects against dopaminergic neuron loss and Lewy body pathology | [ |
| N-methyl D-aspartic acid functionalized gold nanoparticle (GNP-NMDA) | Low molecular weight (LMW) amyloid oligomers | AD | Inhibition of LMW tetramer of amyloid oligomer towards nontoxic aggregation path | [ |
| Protein capped Fe3O4 (PC-Fe3O4) and PC-CdS | Tau protein | AD | Inhibition of Tau aggregation | [ |
ENP-protein interaction studies done using various techniques.
| Techniques Applied | ENPs | Proteins | Parameters Analyzed | References |
|---|---|---|---|---|
| FTIR spectroscopy, | AuNPs | Bovine serum albumin (BSA) | Amount of α-helical structure Conformational change in proteins, secondary and tertiary structural alterations in proteins | [ |
| DLS, TEM, Far-UV spectra, CD spectroscopy | Unmodified TiO2 | α-chymotrypsin, RNase A, and papain | Protein refolding | [ |
| UV/vis spectrophotometry, Raman spectroscopy, electronic paramagnetic resonance (EPR) spectroscopy | Two amorphous pyrogenic silica ENPs | Bovine serum albumin (BSA), hen egg lysozyme (HEL), bovine pancreatic ribonuclease A, RNase and bovine lactoperoxidase (LPO) | Quantify adsorbed protein, surface-driven structural modification, protein orientation on the nanoparticle surface | [ |
| SDS-PAGE, densitometry, AFM, analytical ultracentrifugation (AUC) | SiO2 and CeO2 nanoparticles | Serum proteins and BSA | Adsorption behaviour of proteins | [ |
| Affinity chromatography, UV-visible spectroscopy, TEM, SANS, CD | Silica nanoparticles | Green fluorescent protein (GFP) | Relationship between unfolded proteins, silica nanoparticles and chaperonin | [ |
| TEM, CD | Ultra-small | Amyloid β | Inhibition of fibrillation process, disruption of peptide folding process | [ |
| MD simulation | Monolayer-capped AuNPs | Amyloid β fibrils | Location and binding affinity of nanoparticles with proteins | [ |
| ThT, Congo red assay, FTIR, CD, AFM | Silica nanoparticles (SiNPs) | Hen egg-white lysozyme (HEWL) | Aggregation behavior | [ |